SCHEMBL14031817

SCHEMBL14031817

Cc1cc2nc(-c3n[nH]c4c3CCN(C(=O)NCCc3ccccc3)C4)[nH]c2cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIP5K1C O60331 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
PTGDR2 Q9Y5Y4 3/20 0.40
DRD2 P14416 4/20 0.39
DRD3 P35462 4/20 0.39
TRPV1 Q8NER1 1/20 0.38
KMT2A Q03164 2/20 0.38
P2RX7 Q99572 2/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CCNA1 P78396 1/20 0.38
USP2 O75604 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5067955 0.85 SMN1; SMN2 (0.45) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL5953099 0.81 KMT2A (0.43) PIP5K1CSMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL14032075 0.76 CYP1A2 (0.54) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL5953096 0.73 PIP5K1C (0.44) PIP5K1CSMN1; SMN2KDM4ENPC1ALDH1A1
SCHEMBL5953301 0.72 MAPK1 (0.54) PIP5K1CLMNAMAPT
SCHEMBL5952946 0.72 PIP5K1C (0.42) PIP5K1CSMN1; SMN2NPC1LMNATP53
SCHEMBL5952249 0.72 MAPK1 (0.41) PIP5K1CNPC1
SCHEMBL14032049 0.72 GPBAR1 (0.42) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL1000934 0.71 GPX4 (0.63) TRPV1KMT2A
SCHEMBL14032052 0.71 KMT2A (0.44) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7435820-B2 Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and use AVENTIS PHARMA S.A. (FR) 2008-10-14 US disclosed
US-7435820-B2 Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and use AVENTIS PHARMA S.A. (FR) 2008-10-14 US disclosed